Murine B1-8 Fv fragment (B1-8 Fv)

The Murine B1-8 Fv fragment is a genetically engineered antibody fragment derived from the variable light (VL) and variable heavy (VH) domains of the B1-8 antibody, originally raised in mice (Mus musculus) and known for its specificity to the hapten 4-hydroxy-3-nitrophenylacetyl (NP)[1][4][7]. The Fv (Fragment variable) region consists of the minimal antigen-binding site of an antibody, being composed solely of the variable regions from both light and heavy chains, without any constant regions. In structural studies, the B1-8 Fv has been used extensively as a model for investigating antibody-antigen interactions and as a blueprint for designing engineered antibody fragments, such as diabodies and triabodies[2][3]. Structurally, B1-8 Fv fragments have been crystallized both alone and in complex with haptens—allowing detailed atomic-level examination of antigen recognition and antibody diversity[1][2][3][4][5][7]. These fragments are not considered therapeutic targets themselves but serve as important research tools and structural templates in antibody engineering and immunology. The B1-8 Fv fragment is not a receptor, enzyme, or classic drug target; instead, it is a representative immune molecule widely used in structural and biochemical studies. Its sequence is often adopted for CDR grafting and engineering of other antibody fragments for research applications[8]. No known drugs, approved therapeutic interventions, or clinical biomarkers are associated with the B1-8 Fv fragment itself—it is predominantly a model system and research scaffold, not a therapeutic target.

Other names

B1-8 antibody Fv fragmentB1-8 FVB1-8 fragmentB1-8 Fv (light chain)B1-8 Fv (heavy chain)